Lobbying for who becomes the next Chief Executive (CEO) of the Food and Drugs Authority (FDA), following the sack of its immediate past boss, Hudu Mogtari, is assuming interesting but dangerous twist, with potential candidates maligning each other all in the hopes of grabbing the coveted position.